Results 61 to 70 of about 10,949 (217)

Global Policy Entrepreneurs as Agenda‐Keepers: The UN Secretary‐General's Climate Action During the COVID‐19 Crisis

open access: yesGlobal Policy, EarlyView.
ABSTRACT Crises tend to redirect political attention toward urgent relief efforts, often sidelining long‐term policy priorities. This article examines the role of agenda‐keepers—policy entrepreneurs who work to preserve attention to existing issues when crises threaten to displace them.
Luis Rivera‐Velez, Lucile Maertens
wiley   +1 more source

A Spotlight on Yolk‐sac Tumors: Molecular Pathology, Current Diagnostics, and Novel Therapeutics

open access: yesAndrology, EarlyView.
ABSTRACT Background Yolk‐sac tumors are an aggressive subtype of testicular cancer that significantly contribute to disease progression and therapy resistance, especially in adults. While testicular cancer generally has high cure rates with cisplatin‐based treatment, adult yolk‐sac tumors often appear as components of mixed tumors with poor response to
Evangelos Prokakis   +3 more
wiley   +1 more source

Diosgenin alleviates D-galactose-induced oxidative stress in rats’ brain and liver targeting aging and apoptotic marker genes

open access: yesFrontiers in Molecular Biosciences
The theory of aging is primarily concerned with oxidative stress caused by an imbalance in reactive oxygen species generation and cellular antioxidants.
Ali H. El-Far   +7 more
doaj   +1 more source

Gut microbiota as a novel therapeutic target for eating disorders and obesity

open access: yesBritish Journal of Pharmacology, EarlyView.
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė   +5 more
wiley   +1 more source

Pemphigus Vulgaris: Application of Occlusal Soft Splint with Topical Steroid in the Treatment

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2011
Pemphigus vulgaris (PV) is a rare autoimmune bullous dermatosis with a high mortality rate if untreated. It is characterized by the binding of IgG autoantibodies to desmogleins 3 (DSG 3), a transmembrane glycoprotein adhesion molecule present on ...
G Vivekanandh Reddy   +4 more
doaj   +1 more source

Kommentierung zu Art. 51 DSG

open access: yes, 2023
Datenschutzgesetz (DSG)
Fanger, Reto, Oehri, Isabelle
openaire   +2 more sources

Clinical comparison of mouthrinse and orodispersible film containing cystatins and a statherin‐derived peptide against initial dental erosion

open access: yesEuropean Journal of Oral Sciences, EarlyView.
Abstract This randomized crossover in vivo study compared the anti‐erosive efficacy of solution and orodispersible film (ODF) formulations containing three cystatins (CaneCPI‐5, MaquiCPI‐3, and CsinCPI‐2) combined with a statherin‐derived peptide (StN15pSpS).
Marília Afonso Rabelo Buzalaf   +12 more
wiley   +1 more source

Kommentierung zu Art. 44 DSG

open access: yes, 2023
Datenschutzgesetz (DSG)
Schneider, Danielle, Jauslin, Carl
openaire   +1 more source

Surgical outcomes of patients undergoing TLDG with modified DSG for GC.

open access: yes, 2014
LN, lymph node. DSG, delta-shaped gastroduodenostomy. TLDG, totally laparoscopic distal gastrectomy. GC gastric cancer.
Jianxian Lin (597429)   +8 more
core   +1 more source

Scales of Knowing: Intended Parents' Deliberations on Donor Identifiability in Aotearoa New Zealand

open access: yesFamily Relations, EarlyView.
ABSTRACT Objective This study explored how intended parents choose among known, identifiable‐but‐unknown‐at‐conception and anonymous gamete donors. In New Zealand clinic‐based donation, donor‐conceived people can access identifying donor information at age 18, while some overseas or unregulated arrangements may permit permanent anonymity.
Sharyn Graham Davies   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy